High prevalence of cholestasis, with increased conjugated bile acids in inflammatory bowel diseases patients

doi:10.12998/wjcc.v6.i4.44

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7107)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

612

WORD

238

HTML

3434

Figures (1-2)

178

Tables (1-4)

182

Sum=4644

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

912

Download

1551

Sum=2463

Apr 16, 2018 (publication date) through May 21, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Clin Cases. Apr 16, 2018; 6(4): 44-53
Published online Apr 16, 2018. doi: 10.12998/wjcc.v6.i4.44

Full Size Figure Download Figure

Figure 1 Graphic representation of conjugated¹ or not conjugated primary², secondary³ and tertiary⁴ bile acids.

Citation: Girardin M, Hadengue A, Frossard JL, the Swiss IBD Cohort Study Group. High prevalence of cholestasis, with increased conjugated bile acids in inflammatory bowel diseases patients. World J Clin Cases 2018; 6(4): 44-53
URL: https://www.wjgnet.com/2307-8960/full/v6/i4/44.htm
DOI: https://dx.doi.org/10.12998/wjcc.v6.i4.44